Hanzi Sun - Dept Mol Sci, BeiGene Beijing Co Ltd

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Sonrotoclax Overcomes BCL2 G101V Mutation-Induced Venetoclax Resistance in Preclinical Models of Hematologic Malignancy

Jiuyang Liu, Shuran Li, Qin Wang,Yingcai Feng,Haimei Xing,Xuefei Yang, Ying Guo,Yunhang Guo,Hanzi Sun,Xiaoxin Liu, Shasha Yang, Zhu Mei,Yutong Zhu,Zhenzhen Cheng,Shuaishuai Chen, Min Xu, Wenjing Zhang, Nanyan Wan, Jia Wang,Yanwen Ma,Shuo Zhang, Xudong Luan,Aiying Xu, Lin Li, Haitao Wang,Xiaolong Yang,Yuan Hong,Hai Xue,Xi Yuan,Nan Hu,Xiaomin Song,Zhiwei Wang,Xuesong Liu,Lai Wang,Ye Liu

BLOODno. 18 (2024)

引用0浏览0WOS引用

Abstract 2371: BGB-B167, a first-in-class 4-1BB/CEACAM5 bispecific antibody, exhibits potent in vitro and < for vivo antitumor activity and < for superior safety profile in preclinical models

Zhuo Li, Liang Qu,Xin Chen,Liu Xue, Jie Li, Qi Liu, Jian Sun,Hanzi Sun, Yun Chen,Yuanyuan Xie, Wanyi Wang, Lin Zhu, Penghao Wang,Xiaosui Zhou,Hongjia Hou, Jie Chen, Xinyi Liu,Yilu Zhang,Ning Liu, Xinyi Liang, Shuo Zhang, Xiaoyan Tang,Jing Song,Tong Zhang,Xiaomin Song,Xuesong Liu, Kang Li,Chichi Huang

Cancer Researchno. 6_Supplement (2024): 2371-2371

引用0浏览0引用

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2

Yunhang Guo,Hai Xue,Nan Hu,Ye Liu,Hanzi Sun,Desheng Yu, Ling Qin,Gongyin Shi,Fan Wang, Lei Xin, Weihua Sun, Fan Zhang,Xiaomin Song, Shuran Li, Qiang Wei, Ying Guo,Yong Li, Xiaoxin Liu,Shuaishuai Chen,Taichang Zhang,Yue Wu,Dan Su,Yutong Zhu,Aiying Xu,Haipeng Xu, Shasha Yang, Zhijun Zheng,Junhua Liu,Xuefei Yang,Xi Yuan,Yuan Hong,Xuebing Sun,Yin Guo,Changyou Zhou,Xuesong Liu,Lai Wang,Zhiwei Wang

JOURNAL OF MEDICINAL CHEMISTRYno. 10 (2024): 7836-7858

引用0浏览0WOS引用

Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases

Yunhang Guo, Nan Hu,Ye Liu, Wei Zhang,Desheng Yu,Gongyin Shi,Bo Zhang,Longbo Yin,Min Wei,Xi Yuan,Lusong Luo,Fan Wang,Xiaomin Song, Lei Xin,Qiang Wei,Yong Li, Ying Guo,Shuaishuai Chen,Taichang Zhang,Shuo Zhang, Xing Zhou,Cuining Zhang,Dan Su,Junhua Liu,Zhenzhen Cheng,Jiye Zhang,Haimei Xing,Hanzi Sun,Xin Li,Yuan Zhao, Min He,Yue Wu,Yin Guo,Xuebing Sun, Alice Tian,Changyou Zhou,Steve Young,Xuesong Liu,Lai Wang,Zhiwei Wang

J Med Chem（2023）

引用0浏览0WOS引用

Identification and Characterization of an Unexpected Isomerization Motif in CDRH2 That Affects Antibody Activity

Meiqi Yi, Jian Sun,Hanzi Sun, Yifei Wang, Shan Hou,Beibei Jiang,Yuanyuan Xie, Ruyue Ji,Liu Xue,Xiao Ding,Xiaomin Song,April Xu,Chichi Huang, Quan,Jing Song

mAbsno. 1 (2023): 2215364

引用0浏览0WOS引用

BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models

Ye Liu, Jing Li, Zhuo Li,Qin Wang, Xing Zhou, Xiaoxin Liu, Bo Zhang, Xitao Wang,Sanjia Xu,Hanzi Sun,Xiaomin Song,Xi Yuan, Zhiwei Wang,Xuesong Liu

Cancer Researchno. 12 (2022): 5541-5541

引用0浏览0引用

Tislelizumab Uniquely Binds to the CC′ Loop of PD‐1 with Slow‐dissociated Rate and Complete PD‐L1 Blockage

Yuan Hong,Yingcai Feng,Hanzi Sun,Bo Zhang,Hongfu Wu,Qing Zhu,Yucheng Li,Tong Zhang,Yilu Zhang,Xinxin Cui,Zhuo Li,Xiaomin Song, Kang Li,Mike Liu,Ye Liu

FEBS Open Bio（2021）

引用24浏览0WOS引用

Abstract 2383: the Molecular Binding Mechanism of Tislelizumab, an Investigational Anti-Pd-1 Antibody, is Differentiated from Pembrolizumab and Nivolumab

Yingcai Feng,Yuan Hong,Hanzi Sun,Bo Zhang,Hongfu Wu,Kang Li,Xuesong (Mike) Liu,Ye Liu

Immunology（2019）

引用21浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn